Du är här

2014-04-30

Novo Nordisk A/S : Total number of voting rights and share capital in Novo Nordisk A/S as of 30 April 2014

Bagsværd, Denmark, 30 April 2014
- In accordance with Section 6 of the Danish Statutory Order on Issuers'
Disclosure Obligations, Novo Nordisk is required to publish the total number
of voting rights and the size of the share capital in Novo Nordisk A/S as per
the end of a month where changes therein have occurred.

Further information---------------------------------------------------------------
|Media: |
|Anne Margrethe Hauge +45 4442 3450 amhg@novonordisk.com |
|Ken Inchausti (US) +1 609 514 8316 kiau@novonordisk.com |
| |
|Investors: |
|Kasper Roseeuw Poulsen +45 3079 4303 krop@novonordisk.com |
|Frank Daniel Mersebach +45 3079 0604 fdni@novonordisk.com |
|Lars Borup Jacobsen +45 3075 3479 lbpj@novonordisk.com |
|Daniel Bohsen +45 3079 6376 dabo@novonordisk.com |
|Jannick Lindegaard (US) +1 609 235 8567 jlis@novonordisk.com |
---------------------------------------------------------------

Company announcement No 28 / 2014

Company announcement No 28 2014
http://hugin.info/2013/R/1781602/609616.pdf

---------------------------------------

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novo Nordisk A/S via Globenewswire

HUG#1781602

Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.